Severe thrombocytopenia and fibrinolysis mimicking disseminated intravascular coagulation after rituximab infusion.
Kotsianidis
Ioannis
I
Goutzouvelidis
Aggelos
A
Anastasiades
Athanasios
A
Bouchliou
Irene
I
Nakou
Evangelia
E
Spanoudakis
Emmanouil
E
Christophoridou
Anna V
AV
Margaritis
Dimitrios
D
Bourikas
George
G
Tsatalas
Costas
C
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis* / Q000628:therapy; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008218:Lymphocytosis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D000069283:Rituximab; D012720:Severity of Illness Index; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis* / Q000628:therapy; D013997:Time Factors
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab